TickerFacts.

Disc Medicine, Inc. (IRON): Long-Term Debt

Annual figures by period end, from SEC filings.

$29.16M
As of 2025-12-31
$59.34M
As of 2026-06-30
+15.8%
5-year compound annual growth
2020-12-31: $14.00M2023-12-31: $02024-12-31: $28.32M2025-12-31: $29.16M$29.16M
2020-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$29.16M+3.0%2026-02-26, Balance as of period end
2024-12-31$28.32Mn/a2026-02-26, Balance as of period end
2023-12-31$0n/a2025-02-27, Balance as of period end
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31$14.00Mn/a2022-03-10, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Disc Medicine, Inc. (IRON)2025-12-31$29.16M+3.0%
MannKind Corp (MNKD)2025-12-31$354.64M+883.7%
uniQure N.V. (QURE)2025-12-31$71.92M+8.9%
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31$291.77M-1.4%
Kura Oncology, Inc. (KURA)2025-12-31$9.70M+1.9%
Vera Therapeutics, Inc. (VERA)2025-12-31$74.84M+47.6%
Arvinas, Inc. (ARVN)2025-12-31$600.0K-25.0%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$2.01Bn/a
Cogent Biosciences, Inc. (COGT)2025-12-31$222.90Mn/a

Compare IRON, MNKD, QURE, MRVI side by side · Screen every company in Pharmaceutical Preparations ↗